CONSIDERATION OF APPOINTMENT OF MRS. NEHA SARDA AS INDEPENDENT DIRECTOR OF THE COMPANY SUBJECT TO THE APPROVAL OF SHAREHOLDERS IN GENERAL MEETING
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has made two new board appointments effective 3 January 2026. Mr. Shailendra Pathak, 60, with a diploma in electrical engineering and 40 years of experience, has been appointed as Additional Director to be regularised as Whole Time Director at the upcoming general meeting. Mrs. Neha Sarda, 42, a Company Secretary and M.Com with ICSI membership and 14 years of experience in finance and compliance, has been appointed as Independent Director (Non-Executive), subject to shareholder approval. Both appointees are confirmed as not related to any existing directors or key managerial personnel.
The appointments strengthen governance by adding an Independent Director with finance/compliance expertise and a Whole Time Director with operational experience. Shareholder approval will be sought at the ensuing general meeting; minimal immediate stock price impact expected as these are routine board additions.